Ozempic for $50 a Month on Medicare? I Didn’t Believe It Either
By Solomon · Published: · Updated:
Honestly? When I first heard about this, my reaction was “there’s no way.”
A drug that costs over $1,000 a month — now $50? I knew my phone was about to start ringing. So I dug into it myself, and here’s what I actually found.
The Short Answer
Starting July 2026, some Medicare Part D members can get GLP-1 medications — Ozempic, Wegovy, Mounjaro — for $50 a month. I said “some” on purpose, because this doesn’t apply to everyone automatically.
This comes from the Inflation Reduction Act, which overhauled how Medicare Part D prices drugs. GLP-1 medications just got added to the list of drugs that fall under the new cost cap.
So Why Only “Some” People?
This is the question I get more than any other: “Does this apply to me?”
The answer comes down to why you’re taking the drug. If you’re on Ozempic for Type 2 diabetes, you’re most likely covered. But if you were prescribed it purely for weight loss — no diabetes diagnosis — it depends on your specific plan. Same drug, different reason, different coverage. I know that sounds frustrating. But that’s how Medicare works.
Real People, Real Situations
A 67-year-old client called me recently — she’d been on Ozempic for years to manage her diabetes and was stressed every month about the cost. I pulled up her Part D plan, confirmed the drug was on her formulary, and told her the $50 cap would apply starting this month. Automatically. No paperwork, no calls to the insurance company. I could hear the relief in her voice.